Advanced search
Publication Cover
Dialogues in Clinical Neuroscience Volume 17, 2015 - Issue 2
Submit an article Journal homepage
10,367
Views
66
CrossRef citations to date
0
Altmetric
Clinical Research

Treatment-refractory anxiety; definition, risk factors, and treatment challenges

Ansiedad refractaria al tratamiento: definición, factores de riesgo y desafíos terapéuticos

Anxiété réfractaire au traitement: définition, facteurs de risque et difficultés du traitement

Peter Roy-ByrneProfessor of Psychiatry, University of Washington School of Medicine, Harborview Medical Center, Seattle, Washington, USA; Founding Partner, Psychiatric Medicine Associates, Seattle, Wash-ington, USACorrespondence[email protected]
Pages 191-206 | Published online: 01 Apr 2022

Citations (66)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Harry A. Fagan & David S. Baldwin. (2023) Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions. Expert Review of Neurotherapeutics 23:6, pages 535-548.
Read now
Elliot Hampsey, Adam Perkins & Allan H. Young. (2023) BNC210: an investigational α7-nicotinic acetylcholine receptor modulator for the treatment of anxiety disorders. Expert Opinion on Investigational Drugs 32:4, pages 277-282.
Read now
Robin Blades, Sergio Becerra, Sheldon Jordan, Branon Eusebio, Mark Heatwole, Jessica Iovine, Kennedy Mahdavi, Michael Mamoun, Natalie Nicodemus, Hannah Packham, Norman Spivak & Taylor Kuhn. (2022) The Role of the Insula in Classical and Dissociative PTSD: A Double Case Study. Neurocase 28:2, pages 140-148.
Read now
Jacob Peedicayil. (2020) The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders. Neuropsychiatric Disease and Treatment 16, pages 597-606.
Read now
Hartej Gill, Barjot Gill, David Chen-Li, Sabine El-Halabi, Nelson B. Rodrigues, Danielle S. Cha, Orly Lipsitz, Yena Lee, Joshua Daniel Rosenblat, Amna Majeed, Rodrigo B. Mansur, Flora Nasri, Roger Ho & Roger S. McIntyre. (2020) The emerging role of psilocybin and MDMA in the treatment of mental illness. Expert Review of Neurotherapeutics 20:12, pages 1263-1273.
Read now
Maria Rosaria Anna Muscatello, Rocco Antonio Zoccali & Antonio Bruno. (2020) Is there a time when prescribing pharmacotherapy in psychiatry is futile?. Expert Opinion on Pharmacotherapy 21:7, pages 733-735.
Read now

Articles from other publishers (60)

Yao Wang, Xiaoyu Yang, Xiaojun Ji, Min Liu & Chang Zhou. (2023) Clinical efficacy of escitalopram combined with botulinum toxin A in patients with generalized anxiety disorder and comorbid headache. Psychopharmacology 240:10, pages 2061-2070.
Crossref
Arsalan Aamir Khan, Sarush Ahmed Siddiqui, Farah Yasmin, Syeda Mahnoor Abidi, Rabbia Tariq, Hiba Ahmed, Noor Murtaza, Fareeha Jawed, Sehan Siraj Lashkerwala, Ariba Moin, Syed Muhammad Ismail Shah, Irfan Ullah, Zohaib Yousaf, Muhammad Faizan & Muhammad Huzaifa Shahid. (2023) The Era of Polypills in the Management of Cardiovascular Diseases: Are We There Yet?. Current Problems in Cardiology 48:8, pages 101233.
Crossref
Meryem Kankaynar, Hacer Akgül Ceyhun, Alper Baran, Ekrem Sulukan, Serkan Yildirim, İsmail Bolat, Emine Toraman, Hayrunnisa Nadaroglu, Murat Arslan & Saltuk Buğrahan Ceyhun. (2023) The anxiolytic and circadian regulatory effect of agarwood water extract and its effects on the next generation; zebrafish modelling. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 269, pages 109621.
Crossref
Troy T Rohn, Dean Radin, Tracy Brandmeyer, Barry J Linder, Emile Andriambeloson, Stéphanie Wagner, James Kehler, Ana Vasileva, Huaien Wang, John L Mee & James H Fallon. (2023) Genetic modulation of the HTR2A gene reduces anxiety-related behavior in mice . PNAS Nexus 2:6.
Crossref
Rida Nisar, Zehra Batool & Saida Haider. (2023) Electric foot-shock induces neurobehavioral aberrations due to imbalance in oxidative status, stress hormone, neurochemical profile, and irregular cortical-beta wave pattern in rats: A validated animal model of anxiety. Life Sciences, pages 121707.
Crossref
K. Roseberry, H. Le-Niculescu, D. F. Levey, R. Bhagar, K. Soe, J. Rogers, S. Palkowitz, N. Pina, W. A. Anastasiadis, S. S. Gill, S. M. Kurian, A. Shekhar & A. B. Niculescu. (2023) Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs. Molecular Psychiatry.
Crossref
Nicolas Singewald, Simone B. Sartori, Andreas Reif & Andrew Holmes. (2023) Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder. Neuropharmacology 226, pages 109418.
Crossref
Lindsay Duncan, Gita Taasoobshirazi, Ashana Vaudreuil, Jitendra Sai Kota & Sweta Sneha. (2023) An Evaluation of Impostor Phenomenon in Data Science Students. International Journal of Environmental Research and Public Health 20:5, pages 4115.
Crossref
Ingrid V.E. Carlier, Lotte V. van der Elst, Kim de Jong & Irene M. van Vliet. (2023) Treatment Course Comparison Between Anxiety-Related Disorders in Adult Outpatients. Journal of Nervous & Mental Disease Publish Ahead of Print.
Crossref
Carlos A. Cassiani-Miranda, César A. Arango-Dávila, Jeffrey González-Giraldo, Mario D. Parra-Vera, Jorge Tellez-Vargas & Lilian Rocío Morales-Puerto. (2023) Consenso colombiano del tratamiento con cannabidiol (CBD) puro en psiquiatría. Revista Colombiana de Psiquiatría.
Crossref
Jennifer Apolinário-Hagen, Marie Drüge, Roy Danino & Siegfried Tasseit. 2023. Handbook of Cognitive Behavioral Therapy by Disorder. Handbook of Cognitive Behavioral Therapy by Disorder 79 90 .
M.C. Flux & Christopher A. Lowry. 2023. Neurobiology of Brain Disorders. Neurobiology of Brain Disorders 885 911 .
Alzahra J. Al Omran, Saki Watanabe, Ethan C. Hong, Samantha G. Skinner, Mindy Zhang, Jifeng Zhang, Xuesi M. Shao & Jing Liang. (2022) Dihydromyricetin ameliorates social isolation-induced anxiety by modulating mitochondrial function, antioxidant enzymes, and BDNF. Neurobiology of Stress 21, pages 100499.
Crossref
Edyta Skwirczyńska, Mateusz Kozłowski, Katarzyna Nowak, Oskar Wróblewski, Agnieszka Sompolska-Rzechuła, Sebastian Kwiatkowski & Aneta Cymbaluk-Płoska. (2022) Anxiety Assessment in Polish Students during the Russian–Ukrainian War. International Journal of Environmental Research and Public Health 19:20, pages 13284.
Crossref
Jamie L. Tully, Amelia D. Dahlén, Connor J. Haggarty, Helgi B. Schiöth & Samantha Brooks. (2022) Ketamine treatment for refractory anxiety: A systematic review. British Journal of Clinical Pharmacology 88:10, pages 4412-4426.
Crossref
Shabah M. Shadli, Robert G. Delany, Paul Glue & Neil McNaughton. (2022) Right Frontal Theta: Is It a Response Biomarker for Ketamine’s Therapeutic Action in Anxiety Disorders?. Frontiers in Neuroscience 16.
Crossref
Jieying Guan, Yingting Zhu, Wenmin Huang, Heping Wu, Rongxin Chen, Yuncheng Ma, Lingling Xie, Junting Kuang, Zixuan Li, Aizezi Wumaier & Yehong Zhuo. (2022) A Multifaceted Strategy to Enhance Glaucoma Knowledge and Reduce Anxiety in the Uyghur Population of Rural China. Journal of Ophthalmology 2022, pages 1-9.
Crossref
Srini Pillay, Patrick Candela & Erik Christensen. (2022) Managing Workplace Anxiety during the Pandemic: A Pilot Study of Natural Imagery through 4K Video and Virtual Reality. European Journal of Marketing and Economics 5:1, pages 16-37.
Crossref
Yangfeng Xu, Mitchel Kappen, Kathelijne Peremans, Dimitri De Bundel, Ann Van Eeckhaut, Nick Van Laeken, Filip De Vos, Andre Dobbeleir, Jimmy H. Saunders & Chris Baeken. (2022) Accelerated HF-rTMS Modifies SERT Availability in the Subgenual Anterior Cingulate Cortex: A Canine [11C]DASB Study on the Serotonergic System. Journal of Clinical Medicine 11:6, pages 1531.
Crossref
Xiao Liu, Jingjing Huang, Yuan Jiang, Zhengyu Cao, Maoxiong Wu, Runlu Sun, Zhiteng Chen, Peng Yu, Jianyong Ma, Yangxin Chen, Yuling Zhang & Jingfeng Wang. (2022) IL-6 and IL-8 are likely associated with psychological status in treatment naïve general population. Journal of Affective Disorders 298, pages 337-344.
Crossref
Mitsuhiro Sado, Akira Ninomiya, Maki Nagaoka, Akihiro Koreki, Naho Goto, Yohei Sasaki, Chie Takamori, Teppei Kosugi, Masashi Yamada, Sunre Park, Yasunori Sato, Daisuke Fujisawa, Atsuo Nakagawa & Masaru Mimura. (2022) Effectiveness of Mindfulness-Based Cognitive Therapy With Follow-Up Sessions for Pharmacotherapy-Refractory Anxiety Disorders: Protocol for a Feasibility Randomized Controlled Trial. JMIR Research Protocols 11:1, pages e33776.
Crossref
Jeevan Fernando, Jan Stochl & Karen D. Ersche. (2022) Drug Use in Night Owls May Increase the Risk for Mental Health Problems. Frontiers in Neuroscience 15.
Crossref
Alzahra J. Al Omran, Amy S. Shao, Saki Watanabe, Zeyu Zhang, Jifeng Zhang, Chen Xue, Junji Watanabe, Daryl L. Davies, Xuesi M. Shao & Jing Liang. (2022) Social isolation induces neuroinflammation and microglia overactivation, while dihydromyricetin prevents and improves them. Journal of Neuroinflammation 19:1.
Crossref
Stefan Kloiber & Gerasimos Konstantinou. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 2037 2051 .
Clare Cullen, Nils Kappelmann, Madeha Umer, Ali Abdolizadeh, Muhammad Omair Husain, Sarah Bonato, Gaurav Sharma, Siqi Xue, Abigail Ortiz, Stefan M. Kloiber, Benoit H. Mulsant & Muhammad I. Husain. (2021) Efficacy and acceptability of pharmacotherapy for comorbid anxiety symptoms in bipolar disorder: A systematic review and meta‐analysis. Bipolar Disorders 23:8, pages 754-766.
Crossref
Shabah M. Shadli, Lynne C. Ando, Julia McIntosh, Veema Lodhia, Bruce R. Russell, Ian J. Kirk, Paul Glue & Neil McNaughton. (2021) Right frontal anxiolytic-sensitive EEG ‘theta’ rhythm in the stop-signal task is a theory-based anxiety disorder biomarker. Scientific Reports 11:1.
Crossref
Sari Goldstein Ferber, Gal Shoval, Gil Zalsman, Mario Mikulincer & Aron Weller. (2021) Between Action and Emotional Survival During the COVID-19 era: Sensorimotor Pathways as Control Systems of Transdiagnostic Anxiety-Related Intolerance to Uncertainty. Frontiers in Psychiatry 12.
Crossref
Amir Garakani, James W. Murrough, Rafael C. Freire, Robyn P. Thom, Kaitlyn Larkin, Frank D. Buono & Dan V. Iosifescu. (2021) Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. FOCUS 19:2, pages 222-242.
Crossref
Judith C. Kreutzmann & Markus Fendt. (2021) Intranasal oxytocin compensates for estrus cycle-specific reduction of conditioned safety memory in rats: Implications for psychiatric disorders. Neurobiology of Stress 14, pages 100313.
Crossref
Wicher A. Bokma, Neeltje M. Batelaan, Brenda W.J.H. Penninx & Anton J.L.M. van Balkom. (2021) Evaluating a dimensional approach to treatment resistance in anxiety disorders: A two-year follow-up study. Journal of Affective Disorders Reports 4, pages 100139.
Crossref
Amir Garakani, Rafael C. Freire & James W. Murrough. (2021) Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls. Frontiers in Psychiatry 12.
Crossref
Nicholas G. Norwitz & Uma Naidoo. (2021) Nutrition as Metabolic Treatment for Anxiety. Frontiers in Psychiatry 12.
Crossref
Adele Framer. (2021) What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Therapeutic Advances in Psychopharmacology 11, pages 204512532199127.
Crossref
Elizabeth Whittaker, Alisher R. Dadabayev, Sonalee A. Joshi & Paul Glue. (2021) Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders. Therapeutic Advances in Psychopharmacology 11, pages 204512532110567.
Crossref
Charles W. McMonnies. (2021) Why the symptoms and objective signs of dry eye disease may not correlate. Journal of Optometry 14:1, pages 3-10.
Crossref
Stefan Kloiber & Gerasimos Konstantinou. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 15 .
Amir Garakani, James W. Murrough, Rafael C. Freire, Robyn P. Thom, Kaitlyn Larkin, Frank D. Buono & Dan V. Iosifescu. (2020) Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers in Psychiatry 11.
Crossref
Natalia Szejko, Adam Lombroso, Michael H. Bloch, Angeli Landeros-Weisenberger & James F. Leckman. (2020) Refractory Gilles de la Tourette Syndrome—Many Pieces That Define the Puzzle. Frontiers in Neurology 11.
Crossref
Shannon J. Moore, Geoffrey G. Murphy & Victor A. Cazares. (2020) Turning strains into strengths for understanding psychiatric disorders. Molecular Psychiatry 25:12, pages 3164-3177.
Crossref
Anees Bahji, Arthi Chinna Meyyappan & Emily R. Hawken. (2020) Efficacy and acceptability of cannabinoids for anxiety disorders in adults: A systematic review & meta-analysis. Journal of Psychiatric Research 129, pages 257-264.
Crossref
Joshua Silva, Amy S. Shao, Yi Shen, Daryl L. Davies, Richard W. Olsen, Daniel P. Holschneider, Xuesi M. Shao & Jing Liang. (2020) Modulation of Hippocampal GABAergic Neurotransmission and Gephyrin Levels by Dihydromyricetin Improves Anxiety. Frontiers in Pharmacology 11.
Crossref
Michael D. Banov, Jonathan R. Young, Tyler Dunn & Steven T. Szabo. (2019) Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature. CNS Spectrums 25:3, pages 331-342.
Crossref
Murilo S. de Abreu, Ana C.V.V. Giacomini, Rafael Genario, Nathália Rech, Júlia Carboni, Anton M. Lakstygal, Tamara G. Amstislavskaya, Konstantin A. Demin, Brian E. Leonard, Marli Vlok, Brian H. Harvey, Angelo Piato, Leonardo J.G. Barcellos & Allan V. Kalueff. (2020) Non-pharmacological and pharmacological approaches for psychiatric disorders: Re-appraisal and insights from zebrafish models. Pharmacology Biochemistry and Behavior 193, pages 172928.
Crossref
Menizibeya O. Welcome. (2020) Cellular mechanisms and molecular signaling pathways in stress-induced anxiety, depression, and blood–brain barrier inflammation and leakage. Inflammopharmacology 28:3, pages 643-665.
Crossref
Donald J Robinaugh, Mackenzie L Brown, Olivia M Losiewicz, Payton J Jones, Luana Marques & Amanda W Baker. (2020) Towards a precision psychiatry approach to anxiety disorders with ecological momentary assessment: the example of panic disorder. General Psychiatry 33:1, pages e100161.
Crossref
Simone B. Sartori & Nicolas Singewald. (2019) Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacology & Therapeutics 204, pages 107402.
Crossref
Milica Stanojevic & Dragan Panic. (2019) Treatment of Anxiety Disorders - The Role of Pharmacists. Serbian Journal of Experimental and Clinical Research 0:0.
Crossref
Nicole J LeBlanc & Luana Marques. (2019) In This Issue. General Psychiatry 32:6, pages e100160.
Crossref
Wicher A. Bokma, Guido A. A. M. Wetzer, Jurriaan B. Gehrels, Brenda W. J. H. Penninx, Neeltje M. Batelaan & Anton L. J. M. Balkom. (2019) Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review. Depression and Anxiety 36:9, pages 801-812.
Crossref
Stefano TribertiAlessandra GoriniLucrezia SavioniValeria SebriGabriella Pravettoni. (2019) Avatars and the Disease: Digital Customization as a Resource for Self-Perception Assessment in Breast Cancer Patients. Cyberpsychology, Behavior, and Social Networking 22:8, pages 558-564.
Crossref
Greg Hajcak, Julia Klawohn & Alexandria Meyer. (2019) The Utility of Event-Related Potentials in Clinical Psychology. Annual Review of Clinical Psychology 15:1, pages 71-95.
Crossref
Kang Soo Lee & Sang Hyuk Lee. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry 207 214 .
Alexander Cowell McFarlane. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry 151 164 .
Sanne Y. Smith-Apeldoorn, Jolien K. E. Veraart & Robert A. Schoevers. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry 3 24 .
Chandni ShethHendrik OmbachPaul OlsonPerry F. RenshawShami Kanekar. (2018) Increased Anxiety and Anhedonia in Female Rats Following Exposure to Altitude. High Altitude Medicine & Biology 19:1, pages 81-90.
Crossref
Christina O. Carlisi & Oliver J. Robinson. (2018) The role of prefrontal–subcortical circuitry in negative bias in anxiety: Translational, developmental and treatment perspectives. Brain and Neuroscience Advances 2, pages 239821281877422.
Crossref
Adriane F. Brito, James O. Fajemiroye, Hiasmin F. S. Neri, Dayane M. Silva, Daiany P. B. Silva, Germán Sanz, Boniek G. Vaz, Flávio S. de Carvalho, Paulo C. Ghedini, Luciano M. Lião, Ricardo Menegatti & Elson A. Costa. (2017) Anxiolytic‐like effect of 2‐(4‐((1‐phenyl‐1 H ‐pyrazol‐4‐yl)methyl)piperazin‐1‐yl)ethan‐1‐ol is mediated through the benzodiazepine and nicotinic pathways . Chemical Biology & Drug Design 90:3, pages 432-442.
Crossref
Ned H. Kalin. (2017) Mechanisms underlying the early risk to develop anxiety and depression: A translational approach. European Neuropsychopharmacology 27:6, pages 543-553.
Crossref
James G. Raymond, J. Douglas Steele & Peggy Seriès. (2017) Modeling Trait Anxiety: From Computational Processes to Personality. Frontiers in Psychiatry 8.
Crossref
Laura Campbell-Sills, Peter P. Roy-Byrne, Michelle G. Craske, Alexander Bystritsky, Greer Sullivan & Murray B. Stein. (2016) Improving outcomes for patients with medication-resistant anxiety: effects of collaborative care with cognitive behavioral therapy. Depression and Anxiety 33:12, pages 1099-1106.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.